Epicardial and hepatic fat in Fontan patients is associated with ventricular changes on cardiac MRI

BackgroundEpicardial and hepatic fat are suspected to play a role in cardiac remodeling. The primary objective of this study was to identify the cardiac MRI (CMR) parameters that are associated with indexed epicardial fat volume (EFVi) and hepatic steatosis in patients after the Fontan operation. MethodsThis was a single-center, retrospective analysis of Fontan patients. Epicardial and subcutaneous fat were analyzed with CMR post-processing software, cvi42 (Circle Cardiovascular Imaging, Calgary, Alberta, Canada). Hepatic steatosis was measured with controlled attenuation parameter (CAP) scores via vibration controlled transient elastography. ResultsThe cohort included 81 patients (64% male, median age 16 years). On univariate analysis, EFVi correlated with BMI ({rho}=0.52, p<0.001), age ({rho}=0.48, p<0.001), EDVi ({rho}=0.40, p<0.001), ventricular massi ({rho}=0.39, p<0.001), subcutaneous fat thickness ({rho}=0.31, p<0.01), and inferior vena cava (IVC) flow ({rho}=0.31, p<0.05). On multivariable regression analysis, BMI ({beta} 2.16, p<0.001) and EDVi ({beta} 0.30, p<0.001) were independently associated with EFVi (R2 0.47). Males had higher median CAP scores than females (222 vs 196 dB/m; p<0.05). On univariate analysis, CAP scores correlated with BMI ({rho}=0.53, p<0.001), subcutaneous fat thickness ({rho}=0.48, p<0.001), age ({rho}=0.35, p<0.01), EFVi ({rho}=0.34, p<0.01), and IVC flow ({rho}=0.29, p=0.02). On multivariable analysis, BMI ({beta} 5.8, p<0.001) was independently associated with CAP scores (R2=0.28). There were no significant relationships of EFVi or CAP with adverse clinical events. ConclusionBMI is a strong predictor of hepatic and epicardial fat distribution. Epicardial fat volume is also associated with ventricular dilation and may play a role in adverse cardiac remodeling.